Zhejiang Jolly Pharmaceutical: Announcement on the Progress of Providing Guarantees for the Holding Subsidiary to Apply for Credit Limits from Banks.
Zhejiang Jolly Pharmaceutical: Announcement Regarding the Company's First Share Repurchase
Zhejiang Jolly Pharmaceutical: Investor relations activity record form from August 5th to August 7th, 2024.
Zhejiang Jolly Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Zhejiang Jolly Pharmaceutical: Investor Relations Activity Record Form from July 30th, 2024 to August 1st, 2024.
Zhejiang Jolly Pharmaceutical: Announcement on the shareholder holdings of the top ten shareholders and the top ten unrestricted shareholders regarding share repurchase matters.
Zhejiang Jolly Pharmaceutical: Repurchase report.
Zhejiang Jolly Pharmaceutical: Special report on the collection and use of funds for the first half of 2024.
Zhejiang Jolly Pharmaceutical: Zhejiang Jolly Pharmaceutical Co., Ltd.'s summary table of non-operational fund utilization and other related fund transactions for the first half of 2024.
Zhejiang Jolly Pharmaceutical: Interim report disclosure prompt announcement for 2024.
Zhejiang Jolly Pharmaceutical: Sinolink's continuous supervision and follow-up report on Zhejiang Jolly Pharmaceutical Co., Ltd. for the first half of 2024.
Zhejiang Jolly Pharmaceutical: Half-year report for the year 2024.
Zhejiang Jolly Pharmaceutical: Board of directors resolution announcement.
Zhejiang Jolly Pharmaceutical: Announcement of the Supervisory Board's resolution.
Zhejiang Jolly Pharmaceutical: Summary of Half-Year Report in 2024.
Zhejiang Jolly Pharmaceutical: Announcement regarding the share repurchase plan of the company.
Zhejiang Jolly Pharmaceutical: Announcement on the release of pledges on some shares of the controlling shareholder and actual controller.
Zhejiang Jolly Pharmaceutical: Announcement on the release of pledges on some shares of the controlling shareholder and actual controller.
Zhejiang Jolly Pharmaceutical: 2024 Interim Performance Forecast
Zhejiang Jolly Pharmaceutical: Investor relations activity record from June 26th to June 28th, 2024.
No Data